US Stock MarketDetailed Quotes

VBIV VBI Vaccines

Watchlist
  • 0.603
  • +0.023+3.90%
Close Mar 28 16:00 ET
  • 0.570
  • -0.033-5.44%
Post 18:56 ET
14.27MMarket Cap-61P/E (TTM)

About VBI Vaccines Company

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.

Company Profile

SymbolVBIV
Company NameVBI Vaccines
Listing Date05/09/2016
Founded1965
CEOMr. Jeffrey R. Baxter
MarketNASDAQ
Employees196
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address160 2nd Street,Floor 3
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-830-3031

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey R. Baxter
  • Director, President and Chief Executive Officer
  • 1.83M
  • Dr. David E. Anderson, PhD
  • Chief Scientific Officer
  • 995.44K
  • Nell Beattie
  • Director, Chief Financial Officer and Head of Corporate Development
  • --
  • Dr. Francisco Diaz-Mitoma
  • Chief Medical Officer
  • 1.01M
  • John Robert Dillman
  • Chief Commercial Officer
  • --
  • Avi Mazaltov
  • Global Head of Manufacturing and SciVac General Manager
  • --
  • Dr. Steven Gillis, Pd.D
  • Chairman of the Board
  • 102.50K
  • Dr. Vaughn B. Himes,PhD
  • Independent Director
  • --
  • Dr. Michel De Wilde
  • Independent Director
  • 47.50K
  • Joanne Cordeiro
  • Independent Director
  • 62.50K
  • Blaine McKee
  • Independent Director
  • 60.00K
  • Damian Braga
  • Independent Director
  • 55.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg